E

Medical therapeutic preparations, namely, antisense therapeutics; therapeutics in the nature of pharmaceuticals for treatment of Duchenne Muscular Dystrophy (DMD)

research and development of gene therapeutics, namely, antisense therapeutics; research and development of anti-miRNA technology for the treatment of Duchenne Muscular Dystrophy (DMD); research and development of therapeutics for treatment of Duchenne Muscular Dystrophy (DMD); pharmaceutical and therapeutic research and development